Results 331 to 340 of about 120,861 (346)
Some of the next articles are maybe not open access.
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Nature, 2020Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Nature Medicine, 2018Yuting Sun +2 more
exaly
The evolving landscape of tissue‐agnostic therapies in precision oncology
Ca-A Cancer Journal for CliniciansVivek Subbiah +2 more
exaly
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Nature Reviews Cancer, 2008Ludger Hengst, Joyce M Slingerland
exaly

